The 2.5 mg dose is better called the low-dose starter, because it is the labeled start and now has short direct non-diabetic data behind it. Microdosing has been used for tolerability testing, metabolic-marker support, step-down protocols, and maintenance, not for proven long-term obesity outcomes
That means dosing schedules and handling differ from oral pills, and monitoring for immune reactions or altered clearance is part of clinical use
FIGURE 5 The in vitro experiment indicated UA induced cytoplasmic lipid deposition could be rescued by exogenous LC supplement while be exacerbated by TMZ
UK approval will likely follow that, so realistic availability is 2027 at the earliest and with private prescription first
Contact your doctor promptly if you notice any symptoms of dehydration, such as unusual dry mouth/thirst, fast heartbeat, or dizziness/lightheadedness